Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398405
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-04-29
Brief Title:
A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Shandong Cancer Hospital and Institute
Organization Data
Organization:
Shandong Cancer Hospital and Institute
Class:
OTHER
Study ID:
GTEEC2024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shandong Cancer Hospital and Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Han Xi Zhao
Responsible Party Title:
Deputy Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shandong Cancer Hospital and Institute
Old Name:
None
Old Organization:
None